The patient perspective on biologic DMARD dose reduction in rheumatoid arthritis: A mixed methods study
Verhoef LM et al. Rheumatology (Oxford) 2018: key205. doi: 10.1093/rheumatology/key205
Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.